Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Kogner

Showing results (111-120 of 168) with videos related to

Pageof 17
Sort By:
Molecular Oncology|July 31, 2023
High-content screening of drug combinations of an mPGES-1 inhibitor in multicellular tumor spheroids leads to mechanistic insights into neuroblastoma chemoresistanceAhlem Zaghmi, Erdem Aybay, Long Jiang, et al.
Nature Communications|November 26, 2015
Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistanceMalin Wickström, Cecilia Dyberg, Jelena Milosevic, et al.
Endocrine-Related Cancer|March 31, 2007
The Ras effectors NORE1A and RASSF1A are frequently inactivated in pheochromocytoma and abdominal paragangliomaJanos Geli, Nimrod Kiss, Fredrik Lanner, et al.
Molecular Cancer|July 10, 2013
ERBB3 is a marker of a ganglioneuroblastoma/ganglioneuroma-like expression profile in neuroblastic tumoursAnnica Wilzén, Cecilia Krona, Baldur Sveinbjörnsson, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 26, 2017
Rho-associated kinase is a therapeutic target in neuroblastomaCecilia Dyberg, Susanne Fransson, Teodora Andonova, et al.
Cancers|November 13, 2021
High Expression of <i>PPM1D</i> Induces Tumors Phenotypically Similar to <i>TP53</i> Loss-of-Function Mutations in MiceJelena Milosevic, Susanne Fransson, Miklos Gulyas, et al.
Life Sciences|February 14, 2022
Omega-3 fatty acids decrease CRYAB, production of oncogenic prostaglandin E<sub>2</sub> and suppress tumor growth in medulloblastomaLinda Ljungblad, Filip Bergqvist, Conny Tümmler, et al.
Cancers|December 23, 2023
Telomere Maintenance Mechanisms in a Cohort of High-Risk Neuroblastoma Tumors and Its Relation to Genomic Variants in the <i>TERT</i> and <i>ATRX</i> GenesAnna Djos, Ketan Thombare, Roshan Vaid, et al.
Frontiers in Pharmacology|September 21, 2023
The multiple functions of miR-574-5p in the neuroblastoma tumor microenvironmentEva Proestler, Julia Donzelli, Sheila Nevermann, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2009
Microsomal prostaglandin E synthase 1 determines tumor growth in vivo of prostate and lung cancer cellsHiromi Hanaka, Sven-Christian Pawelzik, John Inge Johnsen, et al.
Pageof 17

Showing results (111-120 of 168) with videos related to

Sort By:
Pageof 17
Molecular Oncology|July 31, 2023
High-content screening of drug combinations of an mPGES-1 inhibitor in multicellular tumor spheroids leads to mechanistic insights into neuroblastoma chemoresistanceAhlem Zaghmi, Erdem Aybay, Long Jiang, et al.
Nature Communications|November 26, 2015
Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistanceMalin Wickström, Cecilia Dyberg, Jelena Milosevic, et al.
Endocrine-Related Cancer|March 31, 2007
The Ras effectors NORE1A and RASSF1A are frequently inactivated in pheochromocytoma and abdominal paragangliomaJanos Geli, Nimrod Kiss, Fredrik Lanner, et al.
Molecular Cancer|July 10, 2013
ERBB3 is a marker of a ganglioneuroblastoma/ganglioneuroma-like expression profile in neuroblastic tumoursAnnica Wilzén, Cecilia Krona, Baldur Sveinbjörnsson, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 26, 2017
Rho-associated kinase is a therapeutic target in neuroblastomaCecilia Dyberg, Susanne Fransson, Teodora Andonova, et al.
Cancers|November 13, 2021
High Expression of <i>PPM1D</i> Induces Tumors Phenotypically Similar to <i>TP53</i> Loss-of-Function Mutations in MiceJelena Milosevic, Susanne Fransson, Miklos Gulyas, et al.
Life Sciences|February 14, 2022
Omega-3 fatty acids decrease CRYAB, production of oncogenic prostaglandin E<sub>2</sub> and suppress tumor growth in medulloblastomaLinda Ljungblad, Filip Bergqvist, Conny Tümmler, et al.
Cancers|December 23, 2023
Telomere Maintenance Mechanisms in a Cohort of High-Risk Neuroblastoma Tumors and Its Relation to Genomic Variants in the <i>TERT</i> and <i>ATRX</i> GenesAnna Djos, Ketan Thombare, Roshan Vaid, et al.
Frontiers in Pharmacology|September 21, 2023
The multiple functions of miR-574-5p in the neuroblastoma tumor microenvironmentEva Proestler, Julia Donzelli, Sheila Nevermann, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2009
Microsomal prostaglandin E synthase 1 determines tumor growth in vivo of prostate and lung cancer cellsHiromi Hanaka, Sven-Christian Pawelzik, John Inge Johnsen, et al.
Pageof 17